Evofem Biosciences, Inc.
|
10.35 USD
|
101.739%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
92.07%
|
CSL Limited
|
2.73 USD
|
106.593%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
103.025%
|
Regen BioPharma, Inc.
|
0.26 USD
|
169.231%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
70.968%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
99.505%
|
Qrons Inc.
|
-0.06 USD
|
-208.748%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
-1243.284%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
-213.043%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
-804.523%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
96.648%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
-1700.0%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
-460.748%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
30.769%
|
Burzynski Research Institute, Inc.
|
-0.01 USD
|
-1664.706%
|
Genscript Biotech Corporation
|
-0.05 USD
|
-296.476%
|
Neon Bloom, Inc.
|
-0.00 USD
|
-11900.0%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
99.646%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
-249.515%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
93.478%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
-105.95%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
-659.494%
|
Mesoblast Limited
|
-0.09 USD
|
-102.02%
|
Marizyme, Inc.
|
-1.44 USD
|
87.5%
|
Genus plc
|
0.12 USD
|
250.0%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
92.275%
|
Pharming Group N.V.
|
-0.02 USD
|
-1018.012%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
-25614.286%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
57.143%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
-86.528%
|
ContraFect Corporation
|
-124.97 USD
|
99.856%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
-328.571%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
-1400.0%
|
IMV Inc.
|
-4.37 USD
|
95.881%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
-408.475%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
-179900.0%
|
ONE Bio Corp.
|
1.43 USD
|
112.587%
|
Accustem Sciences Inc.
|
-0.34 USD
|
47.059%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
68.966%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
-50.0%
|
Q BioMed Inc.
|
-0.08 USD
|
-130.474%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
-156.046%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
45.455%
|
Biomind Labs Inc.
|
-0.02 USD
|
-1011.111%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
99.977%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
-2332.432%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
-7400.0%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
-22400.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
-1945.455%
|
GB Sciences, Inc.
|
-0.00 USD
|
-4290.244%
|
Alpha Cognition Inc.
|
-0.15 USD
|
-20.0%
|
HST Global, Inc.
|
-0.03 USD
|
-545.161%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
-259.281%
|
Halberd Corporation
|
-0.00 USD
|
-179900.0%
|
Enzolytics Inc.
|
-0.00 USD
|
-25614.286%
|
Agentix Corp.
|
-0.04 USD
|
-414.286%
|
Resverlogix Corp.
|
-0.01 USD
|
-1167.606%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
-138.727%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
argenx SE
|
-5.16 USD
|
96.512%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
13946.154%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
817.131%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
-404.202%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
-800.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
-233.952%
|
Zenith Capital Corp.
|
-0.07 USD
|
-157.511%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
-2757.143%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
95.225%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
-35900.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
-97.152%
|
Kadimastem Ltd
|
-0.78 USD
|
76.923%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
96.17%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
-1412.605%
|
LadRx Corporation
|
0.68 USD
|
126.471%
|
Cell Source, Inc.
|
-0.17 USD
|
-5.882%
|
Regen BioPharma, Inc.
|
0.29 USD
|
162.069%
|
NovAccess Global Inc.
|
-0.23 USD
|
21.739%
|
Affymax, Inc.
|
-0.39 USD
|
53.846%
|
Itoco Inc.
|
-0.01 USD
|
-2268.421%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
-1700.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
-7100.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
-3114.286%
|
CytoDyn Inc.
|
-0.05 USD
|
-240.265%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
-35900.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
-710.811%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
99.883%
|
SYBLEU INC
|
-0.02 USD
|
-928.571%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
-1167.606%
|
International Stem Cell Corporation
|
-0.02 USD
|
-997.561%
|
Bioxytran, Inc.
|
-0.03 USD
|
-464.263%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
- USD
|
Infinity%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
-179900.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
97.747%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
84.746%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-0.03 USD
|
-429.412%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
-2757.143%
|
Neutra Corp.
|
-0.00 USD
|
-179900.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
99.809%
|
PureTech Health plc
|
-2.38 USD
|
92.437%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
78.313%
|
IXICO plc
|
-0.02 USD
|
-637.705%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
-216.901%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
86.667%
|
CSL Limited
|
5.47 USD
|
103.291%
|
Cellectis S.A.
|
-1.77 USD
|
89.831%
|